Vitruvian Partners has acquired DeepIntent, a leading healthcare demand-side platform (DSP), for an undisclosed amount. This corporate acquisition signifies a transaction where Vitruvian Partners has bought the specialized marketing technology company, not invested in a funding round. DeepIntent is purpose-built to empower healthcare marketers, agencies, and top brands to plan, activate, and optimize data-driven campaigns with speed and precision within the complex healthcare sector.
DeepIntent's platform uniquely integrates media, identity, and real-world clinical data to enable privacy-safe, omnichannel marketing across various digital screens and channels, including Audio, CTV, Display & Native, DOOH, EHR, and Video. The company's patented technology and proven outcomes deliver measurable audience quality and script lift at scale, serving both Healthcare Professional (HCP) and Direct-to-Consumer (DTC) campaigns. It is recognized for its Health Intelligence, real-time insights, and compliance with privacy standards like HIPAA and NAI.
This acquisition is a strategic move, underscoring Vitruvian Partners' investment in advanced marketing technology and the high-growth healthcare advertising market. For DeepIntent, the transaction provides a new ownership structure and resources to further its mission of shaping the future of healthcare advertising. The synergy is expected to accelerate DeepIntent’s platform innovation, market expansion, and continued leadership in providing sophisticated, data-driven solutions that drive better patient outcomes and campaign performance for its clients.
The combined entity is positioned to enhance DeepIntent's ability to evolve its platform and expand its reach. This corporate acquisition aims to strengthen DeepIntent’s capacity to empower marketers with health intelligence and patented technology, ensuring the delivery of results-driven campaigns that maintain market relevance and impact within the dynamic healthcare landscape.